focus -WSS

focus

author：comprehensive 2025-10-01 22:17:19 - browse：3313

Buildings like hospitals and banks on a web with people operating laptops and phones — health tech coverage from STAT — Adobe

For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug.

But just because it was simple didn’t mean it was going to work.

The bankruptcy of Pear Therapeutics last year proved that selling software-based treatments like drugs is harder than anticipated. Pear received Food and Drug Administration clearance for its app treating substance use disorders and insomnia but insurers mostly refused to cover the novel treatments. Even after hitting roadblock after roadblock, the company stuck to its original plan and ended up vaporizing over $400 million in investment before finally throwing in the towel.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： High breast density mammograms need follow

WSS

NIH nominee Bertagnolli will get October confirmation hearing

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Trump surgeon general acknowledges mistakes during Covid

There's an unseen cost to disruptive road

Medicaid rebukes states for mistakenly disenrolling children

ALS advocates say criticism of new drugs misses bigger picture

entertainment

focus

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

'Make People Better': The CRISPR babies story you probably don't know

Medical leaders decry Supreme Court decision on affirmative action

Stem cell treatment guidelines are released by FDA

Supreme Court strikes down use of affirmative action

What drug price negotiations mean for Medicare Part D

Jerome Adams on the need for new antivirals for Covid

Pumping milk in bathrooms at health conferences is common

Novavax promises a turnaround & Lilly roils the obesity market

A new House health package & hospitals’ new site

hotspot

FDA sets aggressive timeline for overhauling inspection procedures

FDA endorses new sterilization method for medical devices

Medicare drug price lawsuits could be good politics for Biden

Humana sues Biden admin over Medicare Advantage audit rule

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Covid hospitalizations on the rise, Humana says

focus

leisure time

knowledge

focus